Evidence map›Paper›PMID 39847922›Full record

ArticlePlacenta2025

The expression of chromosome 19 miRNA cluster members during insulin sensitivity changes in pregnancy.

Fernanda Alvarado-Flores, Tianjiao Chu, Patrick Catalano, Yoel Sadovsky, Perrie O'Tierney-Ginn

Abstract read
In one paragraph

Article in Placenta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fernanda Alvarado-FloresMount Sinai Chicago Hospital, Chicago, IL, USA.
Tianjiao ChuMagee Women's Research Institute, University of Pittsburgh, Pittsburgh, PA, USA.
Patrick CatalanoMother Infant Research Institute, Tufts Medicine, Boston, MA, USA; Dept Obstetrics & Gynecology, Tufts University, Boston, MA, USA.
Yoel SadovskyMagee Women's Research Institute, University of Pittsburgh, Pittsburgh, PA, USA.
Perrie O'Tierney-GinnMother Infant Research Institute, Tufts Medicine, Boston, MA, USA; Dept Obstetrics & Gynecology, Tufts University, Boston, MA, USA. Electronic address: Perrie.F.OTierney-Ginn@tuftsmedicine.org.

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages to Equity in Health (CLE Health)UM1TR004528 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI GRACE A MCCOMSEY · 2023 to 2026
$32.1M
Placental mRNA profiles associated with maternal insulin resistance and fetal adiposity: maternal-placental crosstalkR01HD091735 · NICHD · TUFTS MEDICAL CENTER · PI O'TIERNEY-GINN, PERRIE F · 2017 to 2020
$1.9M
OMEGA-3 SUPPLMENTATION DECREASES INFLAMMATION AND FETAL OBESITY IN PREGNANCYR01HD057236 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI CATALANO, PATRICK, HAUGUEL-DE MOUZON, SYLVIE · 2009 to 2010
$1.6M
Maternal obesity depresses essential fatty acid transport in the placentaR00HD062841 · NICHD · METROHEALTH MEDICAL CENTER · PI O'TIERNEY-GINN, PERRIE F · 2013 to 2015
$710k
NCATS NIH HHS UM1 TR004528NCRR NIH HHS UL1 RR024989NICHD NIH HHS R00 HD062841NICHD NIH HHS R01 HD057236NICHD NIH HHS R01 HD091735
6 · The paper itself

Abstract

hypothesisDeclines in insulin sensitivity during pregnancy important for fetal growth are associated with impairments in skeletal muscle post-receptor insulin signaling. The primary initiator of these changes is unknown but believed to originate in the placenta. We hypothesize that placental miRNAs are associated with maternal sensitivity changes and impact insulin-sensitive mechanisms in target tissues in vitro.

methodsUsing qPCR, miRNA expression was measured in plasma in early (12-16 wk) and late (34-36 wk) gestation (N = 39) and placental tissue at term (37-41 weeks) (N = 142) collected from independent cohorts. Insulin-sensitive glucose uptake was measured in human skeletal muscle myoblasts exposed to miRNA mimics in vitro. Multi-linear and binomial regression models were generated to test for associations between miRNAs, insulin sensitivity and fetal growth outcomes, adjusting for relevant clinical variables. P < 0.05 was considered significant.

resultsPlacental expression of chromosome 19 miRNA cluster (C19MC) members was higher in patients with obesity and positively correlated with maternal HOMA-IR (Homeostatic Model Assessment for Insulin Resistance; miR-516b-5p, miR-517a-3p, miR-1283). Placental expression of miR-517a-3p was higher in offspring with high adiposity and birthweight. Plasma miR-517a-3p in early and late pregnancy was related to decreases in insulin sensitivity during pregnancy. Mimics for miR-517a-3p and miR-524-3p both impaired insulin-sensitive glucose uptake in human skeletal myocytes in vitro. DISCUSSION: Our findings based on data from two independent pregnancy cohorts and in vitro studies support a role for members of the C19 cluster of miRNAs - particularly miR-517a-3p - in physiological changes in insulin sensitivity over pregnancy, which may impact fetal growth.

Indexed as

Chromosomes, Human, Pair 19Insulin ResistanceMicroRNAsPlacentaAdultFemaleHumansObesityPregnancyMicroRNAsC19MC miRNAsGlucose uptakeInsulin sensitivityPlacentaPregnancySkeletal myocytes

Identifiers

PMID39847922
PMCPMC11867847

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.